INTERNATIONAL PATENT: JUVENA THERAPEUTICS, INC. FILES APPLICATION FOR "IGF2 FUSION PROTEIN FORMULATIONS AND THERAPEUTIC USES THEREOF"

GENEVA, March 19 -- JUVENA THERAPEUTICS, INC. (640 Galveston DriveRedwood City, California 94063) filed a patent application (PCT/US2024/045683) for "IGF2 FUSION PROTEIN FORMULATIONS AND THERAPEUTIC USES THEREOF" on Sep 06, 2024. With publication no. WO/2025/054521, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): O'CONNELL, Jeremy (640 Galveston DriveRedwood City, California 94063)

Abstract: Provided herein, in certain aspects, are pharmaceutical compositions comprising an HSA-IGF2 fusion protein formulated for subcuta...